Business
Naira weakens to 748/$1 against US Dollar at black market
The Nigerian Naira faced a depreciation against the US Dollar in the black market, with the exchange rate averaging N748/$1 on Wednesday, May 17th, 2023.
This marks a decline of 0.13% compared to the previous day’s trading session, where the dollar traded at N747/$1.
Starting the week at N747 per dollar, the Naira experienced a weakening trend, reaching N745/$1 on Thursday due to increased demand for dollars from importers. This followed a period of stability at N738/$1 earlier in the week.
The Naira and the Euro remained steady at an average of N815/£1 on Wednesday, 17th May 2023, the same rate recorded on May 16th, 2023.
READ ALSO: Naira remains stable at black market against Dollar
However, the Naira saw a significant decline of 0.53% against the British Pound, trading at an average of N950/£1 on May 17th, 2023, compared to N945/£1 on May 16th, 2023.
It’s worth noting that the black-market exchange rate can vary across different locations in the country, influenced by factors such as survey timing, demand and supply dynamics, purchasing power, and other relevant factors.
However, the FX rate at the cryptocurrency P2P Exchange market depreciated to trade at a minimum of N754.75/$1, representing a 0.28% decrease from N752.68/$1 that was recorded in the previous day trading session.
This is according to data culled from a P2P exchange platform.
-
Football1 week agoXabi Alonso targets Arda Guler as Chelsea prepare €100m transfer bid
-
Football1 week agoFIFA confirms Jay-Jay Okocha holds World Cup record
-
Business6 days agoDangote cuts petrol, diesel prices again to boost affordability, economic activity
-
Aviation1 week agoInside Airport Luggage Theft: Experts warn of rising insider syndicates
-
Politics7 days agoAmuwo Odofin: Umeadi emerges winner of NDC Reps Primary
-
Featured7 days agoPSG edge Arsenal on penalties to retain Champions League crown
-
Football1 week agoChampions League Final: Talking points ahead of Arsenal vs. PSG match
-
Health4 days agoSenate hearing set to review research on COVID-19 vaccines, cancer concerns

